Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewLercanidipine hydrochloride
Discontinued Product
2959 has been discontinued.
View all Ca<sub>V</sub>1.x Channels (L-type) products.
Description: CaV1.x blocker
Chemical Name: 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-[(3,3-diphenylpropyl)methylamino]-1,1-dimethylethyl methyl ester hydrochloride
Purity: ≥99% (HPLC)
Biological Activity for Lercanidipine hydrochloride
Lercanidipine hydrochloride is a L-type Ca2+ channel blocker that displays higher vascular selectivity than felodipine (Cat. No. 2960). Causes peripheral vasodilation with only weak negative inotropic activity. Antihypertensive. Also exhibits anti-MERS-CoV activity in Vero cells in vitro (IC50 = 2.36 μM).
Technical Data for Lercanidipine hydrochloride
| M. Wt | 648.19 |
| Formula | C36H41N3O6.HCl |
| Storage | Desiccate at +4°C |
| Purity | ≥99% (HPLC) |
| CAS Number | 132866-11-6 |
| PubChem ID | 157917 |
| InChI Key | WMFYOYKPJLRMJI-UHFFFAOYSA-N |
| Smiles | CC1=C(C(OC(C)(C)CN(C)CCC(C4=CC=CC=C4)C3=CC=CC=C3)=O)C(C2=CC=CC([N+]([O-])=O)=C2)C(C(OC)=O)=C(C)N1.Cl |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Product Datasheets for Lercanidipine hydrochloride
References for Lercanidipine hydrochloride
References are publications that support the biological activity of the product.
Bang et al (2003) Lercanidipine. A review of its efficacy in the management of hypertension. Drugs 63 2449 PMID: 14609358
Wirtz and Herzig (2004) Molecular mechanisms of vasoselectivity of the 1,4-dihydropyridine lercanidipine. Br.J.Pharmacol. 142 275 PMID: 15155536
Sironi et al (1996) Antihypertensive effects of lercanidipine in experimental hypertensive rats and dogs. Arzneim.Forsch. 46 152
Ko et al (2021) Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19. Viruses 13 PMID: 33918958
View Related Products by Target
View Related Products by Product Action
Keywords: Lercanidipine hydrochloride, Lercanidipine hydrochloride supplier, Ca2+, channel, blockers, L-type, Calcium, CaV, Channels, L-Type, voltage-gated, voltage-dependent, COVID-19, MERS-CoV, middle, eastern, respiratory, syndrome, Cav1.x, Coronavirus, 2959, Tocris Bioscience
1 Citation for Lercanidipine hydrochloride
Citations are publications that use Tocris products. Selected citations for Lercanidipine hydrochloride include:
Vasigar (2013) Anti-inflammatoryactivity of calciumchannel blocker lercanidipine hydrochloride. J Pharmacol Pharmacother 4 238 PMID: 24250199
Reviews for Lercanidipine hydrochloride
Average Rating: 5 (Based on 1 Review.)
Have you used Lercanidipine hydrochloride?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by:
Lercanidipine measured against other class calcium channel blockers.
By
Anonymous on 02/20/2019
Species: Human
Lercanidipine blocks L-type calcium channels in the smooth muscle cells of blood vessels and the its effectiveness was measured against other class calcium channel blockers.
